Jorge J Castillo

Jorge J Castillo

UNVERIFIED PROFILE

Are you Jorge J Castillo?   Register this Author

Register author
Jorge J Castillo

Jorge J Castillo

Publications by authors named "Jorge J Castillo"

Are you Jorge J Castillo?   Register this Author

100Publications

2524Reads

16Profile Views

CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic review.

Expert Rev Hematol 2019 Oct 30;12(10):873-881. Epub 2019 Jul 30.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1649132DOI Listing
October 2019

Reply to F.D. Leonard.

J Clin Oncol 2019 Oct 19;37(29):2701-2702. Epub 2019 Aug 19.

Mark Bustoros, MD; Romanos Sklavenitis-Pistofidis, MD; Jorge J. Castillo, MD; Steven P. Treon, MD, PhD; and Irene M. Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01708DOI Listing
October 2019

What is new in the treatment of Waldenstrom macroglobulinemia?

Leukemia 2019 Oct 7. Epub 2019 Oct 7.

Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0592-8DOI Listing
October 2019

High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy.

Clin Lymphoma Myeloma Leuk 2019 Sep 15;19(9):e551-e557. Epub 2019 Jun 15.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.06.005DOI Listing
September 2019

Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.

Hematol Oncol Clin North Am 2019 Aug 30;33(4):639-656. Epub 2019 Apr 30.

Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mayer 221, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2019.03.004DOI Listing
August 2019

HOLA! from Latin America to the myeloma world.

Authors:
Jorge J Castillo

Br J Haematol 2019 Aug 4. Epub 2019 Aug 4.

Division of Hematological Malignancies, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16137DOI Listing
August 2019

How we manage Bing-Neel syndrome.

Br J Haematol 2019 Aug 20. Epub 2019 Aug 20.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16167DOI Listing
August 2019

Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age.

Br J Haematol 2019 May 8;185(4):799-802. Epub 2018 Nov 8.

Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15634DOI Listing
May 2019

Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.

Br J Haematol 2019 May 20;185(4):788-790. Epub 2018 Nov 20.

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15627DOI Listing
May 2019

Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenström macroglobulinaemia.

Br J Haematol 2019 Mar 13;184(6):1011-1014. Epub 2018 Mar 13.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15200DOI Listing
March 2019

The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma.

Br J Haematol 2019 Feb 26;184(4):650-653. Epub 2018 Feb 26.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15141DOI Listing
February 2019

Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study.

Cancer 2019 Feb 19;125(4):550-558. Epub 2018 Nov 19.

Department of Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31853
Publisher Site
http://dx.doi.org/10.1002/cncr.31853DOI Listing
February 2019

Ibrutinib and Rituximab in Waldenström's Macroglobulinemia.

N Engl J Med 2018 11;379(20):1973-4

Bing Center for Waldenström’s Macroglobulinemia, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1809505DOI Listing
November 2018

Genomic Landscape of Waldenström Macroglobulinemia.

Hematol Oncol Clin North Am 2018 10 25;32(5):745-752. Epub 2018 Jul 25.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588183072
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2018.05.003DOI Listing
October 2018

Initial Evaluation of the Patient with Waldenström Macroglobulinemia.

Hematol Oncol Clin North Am 2018 10 23;32(5):811-820. Epub 2018 Jul 23.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mayer 221, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2018.05.008DOI Listing
October 2018

Monoclonal Antibodies for Waldenström Macroglobulinemia.

Hematol Oncol Clin North Am 2018 Oct 21;32(5):841-852. Epub 2018 Jul 21.

Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mayer 221, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2018.05.010DOI Listing
October 2018

Waldenström Macroglobulinemia: Lessons Learned from Basic and Clinical Research.

Hematol Oncol Clin North Am 2018 10;32(5):xiii-xiv

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, M548, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588183075
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2018.07.001DOI Listing
October 2018

Viral lymphomagenesis: beyond the usual suspects.

Authors:
Jorge J Castillo

Br J Haematol 2018 09 29;182(5):617-618. Epub 2018 May 29.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15414DOI Listing
September 2018

Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.

J Clin Oncol 2018 09 25;36(27):2755-2761. Epub 2018 Jul 25.

Steven P. Treon, Joshua Gustine, Kirsten Meid, Guang Yang, Lian Xu, Xia Liu, Maria Demos, Amanda Kofides, Nicholas Tsakmaklis, Jiaji G. Chen, Manit Munshi, Gloria Chan, Toni Dubeau, Zachary R. Hunter, and Jorge J. Castillo, Dana-Farber Cancer Institute; Steven P. Treon, Guang Yang, Xia Liu, Noopur Raje, Andrew Yee, Elizabeth O'Donnell, Zachary R. Hunter, and Jorge J. Castillo, Harvard Medical School; and Noopur Raje, Andrew Yee, and Elizabeth O'Donnell, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.6426DOI Listing
September 2018

Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound.

Am J Hematol 2018 08 25;93(4):511-517. Epub 2018 Jan 25.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25023DOI Listing
August 2018

True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis.

Haematologica 2018 08 19;103(8):e374-e376. Epub 2018 Apr 19.

Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.190405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068030PMC
August 2018

Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?

Leuk Lymphoma 2018 07 30;59(7):1753-1755. Epub 2017 Oct 30.

g Division of Hematologic Malignancies , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1393666DOI Listing
July 2018

Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia.

Haematologica 2018 07 22;103(7):e307-e310. Epub 2018 Feb 22.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.186908DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029546PMC
July 2018

Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenström Macroglobulinemia.

Clin Cancer Res 2018 07 16;24(14):3247-3252. Epub 2018 Apr 16.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0152DOI Listing
July 2018

The real world of Waldenström's macroglobulinaemia.

Lancet Haematol 2018 07;5(7):e275-e276

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30091-7DOI Listing
July 2018

EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.

Am J Hematol 2018 07;93(7):953-962

Department of Hematology and Oncology, George Washington Cancer Center, George Washington University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25112DOI Listing
July 2018

Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.

Leuk Lymphoma 2018 06 11;59(6):1375-1383. Epub 2017 Oct 11.

a Department of Medicine , Alpert Medical School of Brown University , Providence , RI , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1387912DOI Listing
June 2018

Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia.

JAMA Oncol 2018 05;4(5):744-745

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0734DOI Listing
May 2018

Spotting the elusive Siberian tiger: Complete response to ibrutinib in a patient with Waldenström Macroglobulinemia.

Am J Hematol 2018 May 14. Epub 2018 May 14.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25142DOI Listing
May 2018

Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia.

Br J Haematol 2018 04 22;181(1):77-85. Epub 2018 Feb 22.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15148DOI Listing
April 2018

The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma.

Leuk Res 2018 04 19;67:82-85. Epub 2018 Feb 19.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.02.011DOI Listing
April 2018

Comparing apples to oranges: A commentary on the Mayo study of MYD88 significance in Waldenstrom's macroglobulinemia.

Am J Hematol 2018 03 23;93(3):E69-E71. Epub 2017 Dec 23.

Department of Medicine, Harvard Medical School; and Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24997DOI Listing
March 2018

MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.

Br J Haematol 2018 02 17;180(4):578-581. Epub 2016 Oct 17.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14386DOI Listing
February 2018

Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Hematol Oncol 2018 Feb 22;36(1):93-97. Epub 2017 Jun 22.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2449DOI Listing
February 2018

Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.

Am J Hematol 2018 01 19;93(1):E1-E3. Epub 2017 Oct 19.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24921DOI Listing
January 2018

Toward personalized treatment in Waldenström macroglobulinemia.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):365-370

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142554PMC
December 2017

Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease.

Leuk Res 2017 11 27;62:12-16. Epub 2017 Sep 27.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.09.020DOI Listing
November 2017

What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapy.

Blood Adv 2017 Nov 28;1(25):2486-2490. Epub 2017 Nov 28.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA; and Department of Medicine, Harvard Medical School, Boston MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017005637DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729614PMC
November 2017

Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome.

Br J Haematol 2017 10 13;179(2):339-341. Epub 2016 Jul 13.

Division of Hematology, Northwell Health Cancer Institute, Hofstra Northwell School of Medicine, Lake Success, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14218DOI Listing
October 2017

Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia.

Br J Haematol 2017 10 5;179(1):106-115. Epub 2017 Jul 5.

Bing Center for Waldenström Macroglobulinemia, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14828DOI Listing
October 2017

Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.

Expert Rev Hematol 2017 08 28;10(8):739-744. Epub 2017 Jun 28.

a Bing Center for Waldenström Macroglobulinemia , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1343661DOI Listing
August 2017

Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia.

Br J Haematol 2017 06 13;177(5):808-813. Epub 2016 Apr 13.

Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14103DOI Listing
June 2017

Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.

Br J Haematol 2017 06 9;177(5):717-725. Epub 2017 May 9.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14743DOI Listing
June 2017

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).

Clin Cancer Res 2017 May 11;23(10):2400-2404. Epub 2016 Nov 11.

Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1918DOI Listing
May 2017

Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.

Leuk Lymphoma 2017 04 22;58(4):773-780. Epub 2016 Aug 22.

b Division of Hematology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1217527DOI Listing
April 2017

Idelalisib in Waldenström macroglobulinemia: high incidence of hepatotoxicity.

Leuk Lymphoma 2017 04 26;58(4):1002-1004. Epub 2016 Aug 26.

a Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1222380DOI Listing
April 2017

To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenström Macroglobulinaemia.

Br J Haematol 2017 03 2;176(5):822-824. Epub 2016 Mar 2.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13996DOI Listing
March 2017

Genomics, Signaling, and Treatment of Waldenström Macroglobulinemia.

J Clin Oncol 2017 Mar 13;35(9):994-1001. Epub 2017 Feb 13.

All authors: Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0814DOI Listing
March 2017

Plasma Cell Disorders.

Authors:
Jorge J Castillo

Prim Care 2016 Dec 14;43(4):677-691. Epub 2016 Oct 14.

Division of Hematological Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mayer 221, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pop.2016.07.002DOI Listing
December 2016

Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders.

Cancer J 2016 Jan-Feb;22(1):34-9

From the Bing Center for Waldenström's Macroglobulinemia and Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/journalppo/2016/01000/Inhibitio
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PPO.0000000000000170DOI Listing
November 2016

Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation.

Leuk Lymphoma 2016 11 16;57(11):2699-701. Epub 2016 Mar 16.

a Division of Hematologic Malignancies , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1157875DOI Listing
November 2016

Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes.

Br J Haematol 2016 Nov 29;175(4):623-630. Epub 2016 Jul 29.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14279DOI Listing
November 2016

Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.

Oncologist 2016 Nov 29;21(11):1377-1386. Epub 2016 Jul 29.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189618PMC
November 2016

Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.

Am J Hematol 2016 10 27;91(10):1032-5. Epub 2016 Jul 27.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusettts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24477DOI Listing
October 2016

Risk factors for progression from smoldering into active myeloma: additional insights from a population-based study.

Authors:
Jorge J Castillo

Eur J Haematol 2016 Sep;97(3):217-8

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12750DOI Listing
September 2016

Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.

Cancer 2016 09 23;122(17):2689-97. Epub 2016 Jun 23.

Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30112DOI Listing
September 2016

Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma.

J Natl Compr Canc Netw 2016 09;14(9):1121-9

From the Department of Medicine, Alpert Medical School of Brown University, and Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island; and Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0121DOI Listing
September 2016

Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma.

Am J Hematol 2016 Aug 2;91(8):E324. Epub 2016 May 2.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24375DOI Listing
August 2016

Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experience.

Ther Adv Hematol 2016 Aug 13;7(4):179-86. Epub 2016 Jun 13.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620716654102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959643PMC
August 2016

Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemia.

Am J Hematol 2016 06 28;91(6):E312-3. Epub 2016 Apr 28.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24366DOI Listing
June 2016

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib.

Blood 2016 06 3;127(25):3237-52. Epub 2016 May 3.

Department of Medical Oncology, Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-695098DOI Listing
June 2016

Future therapeutic options for patients with Waldenström macroglobulinemia.

Best Pract Res Clin Haematol 2016 06 14;29(2):206-215. Epub 2016 Sep 14.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.08.021DOI Listing
June 2016

EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.

Am J Hematol 2016 May;91(5):529-37

Department of Hematology and Oncology, George Washington Cancer Center, George Washington University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24370DOI Listing
May 2016

Survival Claims From Observational Data on Cancer Therapy.

J Clin Oncol 2016 Apr 16;34(12):1425-7. Epub 2016 Feb 16.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.7644DOI Listing
April 2016

Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.

AIDS 2016 Mar;30(5):787-96

aAlpert Medical School of Brown University, Providence bDepartment of Medicine, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island cDivision of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000986DOI Listing
March 2016